2012 年

　2011 年

　2010 年

　2009 年

　2008 年

2012 年

【 著 書 】

1. 久下裕司、玉木長良：E心臓核医学の展望。�@循環器疾患および動脈硬化の分子イメージング。西村恒彦編集　BRAND NEW 心臓核医学。金原出版、東京、2012, pp248-254.
   
   
2. 久保直樹：化学。福士政広編集、山内浩司・久保直樹・津田啓介・大谷浩樹・加藤真一著　第１種放射線取扱主任者試験重要問題集中トレーニング、メジカルビュー社、東京、2012, pp90-152.
   
   
3. 久保直樹：第4章核医学検査技術学。オーム社編。2013年版診療放射線技師国家試験合格! Myテキスト。オーム社編集、オーム社、2012, pp141-189.
   
   
4. 久保直樹：第4章放射化学、福士政広編集　診療放射線技師ポケット・レビュー帳2nd edition.メジカルビュー社、東京、2012, pp121-146.

【 英 文 論 文 な ど 】

1. Yi M, Tao H, Kohanawa M, Zhao S, Kuge Y, Tamaki N: Ferrous Ferric Chloride Downregulates the Inflammatory Response to Rhodococcus aurantiacus Infection in Mice. Biol Pharm Bull. 2012; 34 (12): 2214-2223.
   
   
2. Watanabe A, Nishijima KI, Zhao S, Zhao Y, Tanaka Y, Takemoto H, Strauss HW, Blankenberg FG, Tamaki N, Kuge Y: Quantitative Determination of Apoptosis of Pancreatic β-Cells in a Murine Model of Type 1 Diabetes Mellitus. J Nucl Med. 2012; 53(10):1585-91.
   
   
3. Murakami M, Zhao S, Zhao Y, Chowdhury NF, Yu W, Nishijima K, Takiguchi M, Tamaki N, Kuge Y: Evaluation of changes in the tumor microenvironment after sorafenib therapy by sequential histology and 18F-fluoromisonidazole hypoxia imaging in renal cell carcinoma. Int J Oncol. 2012; 41(5): 1593-600.
   
   
4. Kanegawa N, Kiyono Y, Sugitaa T, Kuge Y, Fujibayasi Y, Saji H: Norepinephrine Transporter Imaging in the Brain of a Rat Model of Depression Using Radioiodinated (2S, αS)-2-(α-(2-iodophenoxy)benzyl)morpholine. Mol Imaging. 2012; 11(4): 280-5.
   
   
5. Ohte N, Narita H, Iida A, Fukuta H, Iizuka N, Hayano J, Kuge Y, Tamaki N, Kimura G: Cardiac β-adrenergic receptor density and myocardial systolic function in the remote noninfarcted region after prior myocardial infarction with left ventricular remodelling. Eur J Nucl Med Mol Imaging. 2012; 39: 1246-1253.
   
   
6. Hirata K, Terasaka S, Shiga T, Hattori N, Magota K, Kobayashi H, YamaguchiS, Houkin K, Tanaka S, Kuge Y, Tamaki N. 18F-Fluoromisonidazole positronemission tomography may differentiate glioblastoma multiforme from lessmalignant gliomas. Eur J Nucl Med Mol Imaging. 2012; 39(5): 760-70.
   
   
7. Kawabori M, Kuroda S, Sugiyama T, Ito M, Shichinohe H, Houkin K, Kuge Y, Tamaki N: Intracerebral, but not intravenous, transplantation of bone marrow stromal cells enhances functional recovery in rat cerebral infarct: An optical imaging study. Neuropathology. 2012; 32(3): 217-26.
   
   
8. Yabe I, Tsuji-Akimoto S, Shiga T, Hamada S, Hirata K, Otsuki M, Kuge Y, Tamaki N, Sasaki H: Writing errors in ALS related to loss of neuronal integrity in the anterior cingulate gyrus. J Neurol Sci. 2012; 315(1-2): 55-9.
   
   
9. Osanai T, Kuroda S, Sugiyama T, Kawabori M, Ito M, Shichinohe H, Kuge Y, Houkin K, Tamaki N, Iwasaki Y: Therapeutic effects of intra-arterial delivery of bone marrow stromal cells in traumatic brain injury of rats - In vivo cell tracking study by near infrared fluorescence imaging. Neurosurgery. 2012; 70(2): 435-44; discussion 444.
   
   
10. Yi M, Furumaki H, Matsuoka S, Sakurai T, Kohanawa M, Zhao S, Kuge Y, Tamaki N, Chiba H: A novel murine model for non-alcoholic steatohepatitis developedby combination of a high-fat diet and oxidized low-density lipoprotein.Lab Invest. 2012; 92(2): 265-81.
    
    
11. Watanabe A, Nishijima K, Zhao S, Tanaka Y, Itoh T, Takemoto H, Tamaki N, Kuge Y: Effect of Glycosylation on Biodistribution of Radiolabeled Glucagon-like Peptide 1. Ann Nucl Med. 2012; 26(2): 184-91.

【 総 説 な ど 】

1. 久下裕司、趙　芫、趙　松吉、玉木長良：　特集1　心臓核医学の最先端　1．動脈硬化イメージング−実験的検討。PETジャーナル、18(Summer): 14-16, 2012.
   
   
2. 久下裕司、西嶋剣一、孫田恵一、趙　松吉、玉木長良：　医薬品開発（又は創薬・育薬）における分子イメージング技術の現状と進歩。 医薬品医療機器レギュラトリーサイエンス、43 (4), 308-313, 2012.
   
   
3. 玉木長良、吉永恵一郎、久下裕司: 交感神経と循環器疾患　交感神経イメージング。 Cardiac Practice, 23 (2): 143-147, 2012.
   
   
4. 玉木長良、吉永恵一郎、久下裕司: 特集冠動脈疾患の診断・治療における画像診断の進歩　分子イメージングによる冠動脈病変評価、 Cardiac Practice, 23 (1): 23-27, 2012.
   
   
5. 藤下稔雄、小浦哲、小玉亮一、井手口猛、久保直樹、越智誠：Emission dataとCTAC dataの位置ずれによる脳血流SPECT countsの変化。日本放射線技師会誌、 59(5):527-531, 2012.
   
   
6. 久保直樹：フィルタ補正逆投影法・逐次近似法について、START, 48:13-15, 2012.
   
   
7. 久保直樹：分子イメージング技術の向上のために−教育プログラムの構築と実践−。平成24年度放射線安全取扱部会年次大会要旨集、77-78, 2012.
   
   
8. 久保直樹：核医学専門技師としての責務。北海道放射線技術雑誌、73:39-41, 2012.
   
   

2011 年

【 著 書 】

1. 久下裕司、関興一：第９章　放射線と生体。9.1 身の回りの放射線とその生体への影響。佐治英郎 編集。ＮＥＷ 放射化学・放射薬品学。廣川書店、東京、2011.
   
   
2. 玉木長良、久下裕司：核医学検査。動脈硬化の内科治療に迫る、新・心臓病診療プラクティス16、吉川純一、笠貫宏、土師一夫、別府慎太郎、松崎益徳、（編集）、文光堂、2011, pp133-138.
   
   
3. 久保直樹：第4章核医学検査技術学。オーム社編。診療放射線技師国家試験合格! Myテキスト。オーム社（編集）、オーム社、 2011, pp133-175.
   

【 英 文 論 文 な ど 】

1. Hua Li, Songji Zhao, Yongnan Jin, Ken-ichi Nishijima, Hiromichi Akizawa, Kazue Ohkura, Nagara Tamaki, Yuji Kuge: A radiolabeled uracil derivative as a novel SPECT probe for thymidine phosphorylase: Suppressed accumulation into tumor cells by target gene knockdown. Nucl Med Comn. 2011; 32 (12): 1211-5.
   
   
2. Sano K, Temma T, Azuma T, Nakai R, Narazaki M, Kuge Y, Saji H: A Pre-targeting Strategy for MR Imaging of Functional Molecules Using Dendritic Gd-Based Contrast Agents. Mol Imaging Biol. 2011; 13 (6): 1196-1203
   
   
3. Kudo T, Ueda M, Konishi H, Kawashima H, Kuge Y, Mukai T, Miyano A, Tanaka S, Kizaka-Kondoh S, Hiraoka M, Saji H: PET Imaging of Hypoxia-Inducible Factor-1-Active Tumor Cells with Pretargeted Oxygen-Dependent Degradable Streptavidin and a Novel (18)F-Labeled Biotin Derivative. Mol Imaging Biol. 2011; 13 (5): 1003-10.
   
   
4. Zhao S, Kuge Y, Yi M, Zhao Y, Hatano T, Magota K, Nishijima K, Kohanawa M, Tamaki N: Dynamic (11)C-methionine PET analysis has an additional value for differentiating malignant tumors from granulomas: an experimental study using small animal PET. Eur J Nucl Med Mol Imaging. 2011; 38(10): 1876-86.
   
   
5. Zhao Y, Zhao S, Kuge Y, Strauss WH, Blankenberg FG, Tamaki N: Localization of Deoxyglucose and Annexin A5 in Experimental Atheroma Correlates with Macrophage Infiltration but not Lipid Deposition in the Lesion. Mol Imaging Biol. 2011; 13(4): 712-20.
   
   
6. Sugiyama T, Kuroda S, Osanai T, Shichinohe H, Kuge Y, Ito M, Kawabori M, Iwasaki Y: Near-infrared fluorescence labeling allows non-invasive tracking of bone marrow stromal cells transplanted into rat infarct brain. Neurosurgery. 2011; 68(4): 1036-47; discussion 1047.
   
   
7. Takeuchi S, Zhao S, Kuge Y, Zhao Y, Nishijima KI, Hatano T, Shimizu Y, Kinoshita I, Tamaki N, Dosaka-Akita H: 18F-Fluorothymidine PET/CT as an early predictor of tumor response to treatment with cetuximab in human lung cancer xenografts. Oncol Rep. 2011; 26: 725-730.
   
   
8. Hirata K, Kuge Y, Yokota C, Harada A, Kokame K, Inoue H, Kawashima H, Hanzawa H, Shono Y, Saji H, Minematsu K, Tamaki N. Gene and protein analysis of brain derived neurotrophic factor expression in relation to neurological recovery induced by an enriched environment in a rat stroke model. Neurosci Lett. 2011; 495(3): 210-215.
   
   
9. Okamoto S, Shiga T, Hattori N, Kubo N, Takei T, Katoh N, Sawamura Y, Nishijima K, Kuge Y, Tamaki N: Semiquantitative analysis of C-11 methionine PET may distinguish brain tumor recurrence from radiation necrosis even in small lesions. Ann Nucl Med. 2011; 25(3): 213-20.
   
   
10. Magota K, Kubo N, Kuge Y, Nishijima K, Zhao S, Tamaki N: Performance characterization of the Inveon preclinical small-animal PET/SPECT/CT system for multimodality imaging. Eur J Nucl Med Mol Imaging. 2011; 38(4): 742-52.
    
    
11. Shono Y, Yokota C, Kuge Y, Kido S, Harada A, Kokame K, Inoue H, Hotta M, Hirata K, Saji H, Tamaki N, Minematsu K: Gene expression associated with an enriched environment after transient focal ischemia. Brain Res. 2011; 1376: 60-65
    
    
12. Hirata K, Hattori N, Katoh C, Shiga T, Kuroda S, Kubo N, Usui R, Kuge Y, Tamaki N: Regional partition coefficient of water in patients with cerebrovascular disease and its effect on rCBF assessment. Nucl Med Commun. 2011; 32(1): 63-70.
    
    
13. Morimoto Y, Ueno Y, Takeuchi W, Kojima S, Matsuzaki K, Ishitsu T, Umegaki K, Kiyanagi Y, Kubo N, Katoh C, Shiga T, Shirato H, Tamaki N. Development of a 3D brain PET scanner using CdTe semiconductor detectors and its first clinical application. IEEE Trans Nucl Sci. 58(5):2181-2189, 2011
    
    

【 総 説 な ど 】

1. 久下裕司、竹井俊樹、趙　松吉：　特集１　次世代腫瘍分子イメージング　４．アポトーシスイメージングプローブ。ＰＥＴジャーナル、13(Spring): 23-25, 2011.
   
   
2. 久下　裕司、西嶋剣一、趙　松吉：　特集１　核医学検査の新しい展開〜治療戦略への応用　治療戦略に役立つ放射性薬剤の開発。映像情報メディカル、 43 (11), 842-849, 2011.
   

2010 年

【 編 書 】

1. Tamaki N, Kuge Y (eds.) :Molecular Imaging for Integrated Medical Therapy and Drug Development. Springer (Springer Science+Business Media), Heidelberger, 2010.
   

【 著 書 】

1. Tamaki N, Kuge Y: Advances in Molecular Imaging. In: Molecular Imaging for Integrated Medical Therapy and Drug Development. In: Molecular Imaging for Integrated Medical Therapy and Drug Development (Tamaki N, Kuge Y eds.), Springer (Springer Science+Business Media), Heidelberger, 2010, pp.1-4.
   
   
2. Kuge Y, Zhao S, Takei T, Tamaki N: Molecular Imaging for the Assessment of Tumor Malignancy and Response to Therapy. In: Molecular Imaging for Integrated Medical Therapy and Drug Development (Tamaki N, Kuge Y eds.), Springer (Springer Science+Business Media), Heidelberger, 2010, pp.19-29.
   
   
3. Magota K, Kubo N, Narihiro K, Suzuki K, Nishijima K, Zhao S, Kuge Y, Tamaki N: Initial Performance Measurement of an Integrated PET/SPECT/CT System for Small Animal Imaging. In: Molecular Imaging for Integrated Medical Therapy and Drug Development (Tamaki N, Kuge Y eds.), Springer (Springer Science+Business Media), Heidelberger, 2010, pp.60-68.
   
   
4. Zhao Y, Kuge Y, Zhao S, Strauss HW, Blankenberg FG, Tamaki N: Molecular Imaging of Atherosclerotic Plaque Vulnerability: Comparison between 18F-FDG and 99mTc-Annexin A5. In: Molecular Imaging for Integrated Medical Therapy and Drug Development (Tamaki N, Kuge Y eds.), Springer (Springer Science+Business Media), Heidelberger, 2010, pp.69-77.
   
   
5. Kuroda S, Kuge Y, Tamaki N, Iwasaki Y: Bone Marrow Stromal Cell Transplantation for Central Nervous System Disorders ?Perspective for Translational Research and Clinical Application. In: Molecular Imaging for Integrated Medical Therapy and Drug Development (Tamaki N, Kuge Y eds.), Springer (Springer Science+Business Media), Heidelberger, 2010, pp.126-138.
   
   
6. Sugiyama T, Kuroda S, Osanai T, Maruichi K, Chiba Y, Shichinohe H, Kuge Y, Tamaki N, Iwasaki Y: Non-invasive Optical Tracking of Bone Marrow Stromal Cells Transplanted into Rat Cerebral Infarct. In: Molecular Imaging for Integrated Medical Therapy and Drug Development (Tamaki N, Kuge Y eds.), Springer (Springer Science+Business Media), Heidelberger, 2010, pp.139-144.
   
   
7. 久下裕司、西嶋剣一、玉木長良：第18章 心臓核医学の分子イメージング　1.心筋交感神経・受容体イメージング。編集主幹：米倉義晴　編集委員：伊藤正敏、窪田和雄、佐治英郎、玉木長良、中川恵一、畑澤　順、間賀田泰寛、渡辺恭良、寺田弘司。臨床医とコメディカルのための最新クリニカルPET。先端医療技術研究所、東京、2010.
   
   
8. 玉木長良、吉永恵一郎、久下裕司：第1章 心・血管病の分子イメージングの歴史、現状。今泉　勉、Jagat Narula監修、田原宣広編集。心・血管病の分子イメージング。永井書店、大阪、2010.
   

【 英 文 論 文 な ど 】

1. Akizawa H, Zhao S, Takahashi M, Nishijima K, Kuge Y, Tamaki N, Seki K, Ohkura K: In vitro and in vivo evaluations of a radioiodinated thymidine phosphorylase inhibitor as a tumor diagnostic agent for angiogenic enzyme imaging. Nuclear Medicine and Biology 37(4): 427-432, 2010.3
   
   
2. Sano K, Temma T, Kuge Y, Kudo T, Kamihashi J, Zhao S, Saji H: Radioimmunodetection　of　membrane type-1 matrix metalloproteinase relevant to tumor malignancy with a pre-targeting method. Biol.Pharm.Bull 33(9): 1589-1595, 2010.9
   
   
3. Ueda M, Iida Y, Tominaga A, Yoneyama T, Ogawa M, Magata Y, Nishimura H, Kuge Y, Saji H: Nicotinic acetylcholine receptors expressed in the ventralposterolateral thalamic nucleus play an important role in anti-allodynic effects. Br J Pharmacol. 2010; 159: 1201?1210.
   
   
4. Seki KI, Noya Y, Mikami Y, Taneda S, Suzuki AK, Kuge Y, Ohkura K: Isolation and identification of new vasodilative substances in diesel exhaust particles. Environ Sci Pollut Res Int. 2010;17(3):717-23.
   
   
5. Aita K, Temma T, Shimizu Y, Kuge Y, Seki KI, Saji H: Synthesis of a New NIR Fluorescent Nd Complex Labeling Agent. J Fluoresc. 2010; 20(1):225-34.
   
   
6. Aita K, Temma T, Kuge Y, Seki KI, Saji H: NIR fluorescent ytterbium compound for in vivo fluorescence molecular imaging. Luminescence. 2010; 25: 19-24.
   
   
7. Temma T, Ogawa Y, Kuge Y, Ishino S, Takai N, Nishigori K, Shiomi M, Ono M, Saji H: Tissue factor detection for selectively discriminating unstable plaques in an atherosclerotic rabbit model. J Nucl Med. 2010; 51(12): 1979-1986.
   
   
8. Kuge Y, Takai N, Ogawa Y, Temma T, Zhao Y, Nishigori K, Ishino S, Kamihashi J, Kiyono Y, Shiomi M, Saji H: Imaging with radiolabelled anti-membrane type 1 matrix metalloproteinase (MT1-MMP) antibody: potentials for characterizing atherosclerotic plaques. Eur J Nucl Med Mol Imaging. 2010; 37(11): 2093-2104.
   
   
9. Ueda M, Kudo T, Kuge Y, Mukai T, Tanaka S, Konishi H, Miyano A, Ono M, Kizaka-Kondoh S, Hiraoka M, Saji H: Rapid detection of hypoxia-inducible factor-1-active tumours: pretargeted imaging with a protein degrading in a mechanism similar to hypoxia-inducible factor-1alpha. Eur J Nucl Med Mol Imaging. 2010;37(8):1566-1574.
   

2009 年

【 著 書 】

1. Kuge Y: Chapter 11 Technetium-99m Annexin-A5 for Apoptosis Imaging. In: 　Technetium-99m Radiopharmaceuticals: Status and Trends. IAEA RADIOISOTOPES AND RADIOPHARMACEUTICALS SERIES No. 1. INTERNATIONAL ATOMIC ENERGY AGENCY. VIENNA. 2009; 241-253.
   

【 英 文 論 文 な ど 】

1. Kuge Y, Obokata N , Kimura H, Katada Y, Temma T, Sugimoto Y, Aita K, Seki K, Tamaki N, Saji H: Synthesis and evaluation of a radioiodinated Lumiracoxib derivative for the imaging of cyclooxygenase-2 expression. Nucl Med Biol. 2009; 36(8): 869-876. 　
   
   
2. Kudo T, Ueda M, Kuge Y, Mukai T, Tanaka S, Masutani M, Kiyono Y, Kizaka-Kondoh S, Hiraoka M, Saji H: Imaging of HIF-1-active tumor hypoxia using a protein effectively delivered to and specifically stabilized in HIF-1-active tumor cells. J Nucl Med. 2009; 50(6): 942-949.
   
   
3. Temma T, Sano K, Kuge Y, Kamihashi J, Takai N, Ogawa Y, Saji H: Development of a radiolabeled probe for detecting membrane type-1 matrix metalloproteinase on malignant tumors. Biol Pharm Bull. 2009; 32(7): 1272-1277.
   
   
4. Herrmann K, Takei T, Kanegae K, Shiga T, Buck AK, Altomonte J, Schwaiger M, Schuster T, Nishijima K, Kuge Y, Tamaki N: Clinical Value and Limitations of [(11)C]-Methionine PET for Detection and Localization of Suspected Parathyroid Adenomas. Mol Imaging Biol. 2009; 11(5): 356-363. [Epub ahead of print]
   
   
5. Naya M, Tsukamoto T, Morita K, Katoh C, Nishijima K, Komatsu H, Yamada S, Kuge Y, Tamaki N, Tsutsui H: Myocardial {beta}-Adrenergic Receptor Density Assessed by 11C-CGP12177 PET Predicts Improvement of Cardiac Function After Carvedilol reatment in Patients with Idiopathic Dilated Cardiomyopathy. J Nucl Med. 2009; 50(2): 220-225
   
   
6. Seki K, Noya Y, Mikami Y, Taneda S, Suzuki AK, Kuge Y, Ohkura K: Isolation and identification of new vasodilative substances in diesel exhaust particles. Environ Sci Pollut Res Int. 2009 Jun 26. [Epub ahead of print]
   

【 総 説 な ど 】

1. Kuge Y, Zhao S, Takei T, Tamaki N: Molecular Imaging of Apoptosis with Radio-Labeled Annexin A5 Focused on the Evaluation of Tumor Response to Chemotherapy. Anti-Cancer Agents in Medicinal Chemistry. 2009; 9: 1003-1011.
   

2008 年

【 英 文 論 文 な ど 】

1. Takahashi M, Seki K, Nishijima K, Zhao S, Kuge Y, Tamaki N, Ohkura K: Synthesis of a radioiodinated thymidine phosphorylase inhibitor and its preliminary evaluation as a potential SPECT tracer for angiogenic enzyme expression. J Labelled Compounds and Radiopharmaceuticals. 2008; 51(11): 384-387.
   
   
2. Yimin, Kohanawa M, Ozaki M, Haga S, Fujikawa K, Zhao S, Kuge Y, Tamaki N: Mutual modulation between interleukin-10 and interleukin-6 induced by Rhodococcus aurantiacus infection in mice. Microbes Infect. 2008; 10(14-15): 1450-1458.
   
   
3. Zhao Y, Kuge Y, Zhao S, Strauss HW, Blankenberg FG, Tamaki N: Prolonged High-Fat Feeding Enhances Aortic 18F-FDG and 99mTc-Annexin A5 Uptake in Apolipoprotein E-Deficient and Wild-Type C57BL/6J Mice. J Nucl Med. 2008; 49(10): 1707-1714.
   
   
4. Ishino S, Mukai T, Kuge Y, Kume N, Ogawa M, Abe J, Takai N, Kamihashi J,Shiomi M, Minami M, Kita T, Saji H: Ｔargeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque. J Nucl Med 2008; 49(10): 1677-1685
   
   
5. Takahashi M, Seki K, Nishijima K, Kuge Y, Tamaki N, Ohkura K: SYNTHESIS OF 11C-LABELED URACIL DERIVATIVE FOR A PET TRACER TARGETING THYMIDINE PHOSPHORYLASE. Heterocycles. 2008; 76(1): 237-241.
   
   
6. Kuge Y, Kume N, Ishino S, Takai N, Ogawa Y, Mukai T, Minami M, Shiomi M, Saji H: Prominent lectin-like oxidized LDL receptor-1 (LOX-1) expression in atherosclerotic lesions is associated with tissue factor expression and apoptosis in hypercholesterolemic rabbits. Biol Pharm Bull. 2008; 31(8): 1475-1482.
   
   
7. Temma T, Kuge Y, Sano K, Kamihashi J, Obokata N, Kawashima H, Magata Y, Saji H: PET O-15 cerebral blood flow and metabolism after acute stroke in spontaneously hypertensive rats. Brain Res. 2008; 1212: 18-24.
   
   
8. Wu YW, Naya M, Tsukamoto T, Komatsu H, Morita K, Yoshinaga K, Kuge Y, Tsutsui H, Tamaki N: Heterogeneous Reduction of Myocardial Oxidative Metabolism in Patients With Ischemic and Dilated Cardiomyopathy Using C-11 Acetate PET. Circ J. 2008; 72(5): 786-792.
   
   
9. Seki K, Aizawa K, Sugaoi T, Kimura M, Ohkura K: Synthesis of Highly Conjugated Arylpropenylidene-1,3-Diazin-2-ones via Paterno-Buchi Reaction by Photoreaction of 5-Fluoro-1,3-dimethyluracil with 1-Methoxynaphthalenes. Chemistry Letters. 2008; 37 (8): 872-873.
   
   
10. Noya Y, Mikami Y, Taneda S, Mori Y, Suzuki　ＡＫ, Ohkura K, Yamaki K, Yoshino S, Seki K: Improvement of an efficient separation method for chemicals in diesel exhaust particles: analysis for nitrophenols. K ESPR (Environmental Science and Pollution Research). 2008; 5 (4): 318-321.
    
    
11. Zhao S, Kuge Y, Kohanawa M, Takahashi T, Zhao Y, Yi M, Kanegae K, Seki K, Tamaki N: Usefulness of 11C-Methionine for Differentiating Tumors from Granulomas in Experimental Rat Models: A Comparison with 18F-FDG and 18F-FLT. J Nucl Med. 2008; 49(1): 135-141
    
12. Kiyono Y, Sugita T, Ueda M, Kawashima H, Kanegawa N, Kuge Y, Fujibayashi Y, Saji H: Evaluation of radioiodinated (2S,alphaS)-2-(alpha-(2-iodophenoxy)benzyl)morpholine as a radioligand for imaging of norepinephrine transporter in the heart. Nucl Med Biol. 2008; 35(2): 213-218.